[ad_1]
The University of Oxford and AstraZeneca corona vaccine trials are closed when a person becomes ill. But the trial of the experimental Kavid-19 vaccine will be relaunched starting Saturday. Such information has become known in a Bloomberg report.
Oxford University is launching a trial of the vaccine after receiving a green signal from the UK government. They have returned to work in full force.
Oxford said in a statement that the UK’s Medicines Health Regulatory Authority (MHRA) had recommended resuming the trial after reviewing the safety data. However, the participants did not disclose any information about their illness.
In a statement, AstraZeneca said that the UK committee had completed the investigation. The Medicines Health Regulatory Authority has recommended that it be safe to resume trials in the UK.
The statements from AstraZeneca and Oxford on Saturday did not provide any information on trials outside the UK. Trials have only been reported in the UK.
Source: Bloomberg.
[ad_2]
